CD4 cell count at initiation of ART, long-term likelihood of achieving CD4 >750 cells/mm3 and mortality risk.

about

Sex disparities in outcomes among adults on long-term antiretroviral treatment in northern Nigeria.Vitamin D status and immune function reconstitution in HIV-infected men initiating therapy.

P2860

Q39283671-D1309EC6-88FD-4FCB-96D1-6A2599302FF5 Q52726138-53583AB4-D468-453B-B02C-F78A851F9CB4

P2860

CD4 cell count at initiation of ART, long-term likelihood of achieving CD4 >750 cells/mm3 and mortality risk.

Item

http://www.wikidata.org/entity/Q39665419

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

CD4 cell count at initiation o ...... cells/mm3 and mortality risk.

@en

CD4 cell count at initiation o ...... cells/mm3 and mortality risk.

@nl

type

Item

label

CD4 cell count at initiation o ...... cells/mm3 and mortality risk.

@en

CD4 cell count at initiation o ...... cells/mm3 and mortality risk.

@nl

prefLabel

CD4 cell count at initiation o ...... cells/mm3 and mortality risk.

@en

CD4 cell count at initiation o ...... cells/mm3 and mortality risk.

@nl

P1476

CD4 cell count at initiation o ...... cells/mm3 and mortality risk.

@en

P2093

B Yangco

http://www.w3.org/2001/XMLSchema#string

C Armon

http://www.w3.org/2001/XMLSchema#string

F J Palella

http://www.w3.org/2001/XMLSchema#string

HOPS Investigators

http://www.w3.org/2001/XMLSchema#string

J S Chmiel

http://www.w3.org/2001/XMLSchema#string

J T Brooks

http://www.w3.org/2001/XMLSchema#string

K Buchacz

http://www.w3.org/2001/XMLSchema#string

K Lichtenstein

http://www.w3.org/2001/XMLSchema#string

K Wood

http://www.w3.org/2001/XMLSchema#string

M Durham

http://www.w3.org/2001/XMLSchema#string

P2860

Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Effect of early versus deferred antiretroviral therapy for HIV on survival.

Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997-2011.

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.

Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.

Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial

Cause-specific mortality among HIV-infected individuals, by CD4(+) cell count at HAART initiation, compared with HIV-uninfected individuals

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals.

P304

2654-2662

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKW196

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27330061

http://www.w3.org/2001/XMLSchema#string

CD4 cell count at initiation of ART, long-term likelihood of achieving CD4 >750 cells/mm3 and mortality risk.

about

P2860

P2860

CD4 cell count at initiation of ART, long-term likelihood of achieving CD4 >750 cells/mm3 and mortality risk.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698